{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:49:16Z","timestamp":1785876556667,"version":"3.56.0"},"reference-count":111,"publisher":"Elsevier","isbn-type":[{"value":"9780443345258","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.irn.2026.02.004","type":"book-chapter","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T12:24:24Z","timestamp":1773491064000},"page":"363-396","source":"Crossref","is-referenced-by-count":0,"title":["Brain lipid dysregulation as a driver of energy metabolism failure in Alzheimer\u2019s disease"],"prefix":"10.1016","author":[{"given":"Nitin","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotirmoy","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/bs.irn.2026.02.004_bib1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10522-017-9710-z","article-title":"Lipid (per) oxidation in mitochondria: An emerging target in the ageing process?","volume":"18","author":"Ademowo","year":"2017","journal-title":"Biogerontology"},{"issue":"10","key":"10.1016\/bs.irn.2026.02.004_bib2","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.3390\/cells10102591","article-title":"Lipid profiling of AD brain highlights enrichment in glycerol(phospho)lipid, and sphingolipid metabolism","volume":"10","author":"Akyol","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/bs.irn.2026.02.004_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100498","article-title":"APOE genotype dictates lipidomic signatures in primary human hepatocytes","volume":"65","author":"Almeida","year":"2024","journal-title":"Journal of Lipid Research"},{"issue":"5","key":"10.1016\/bs.irn.2026.02.004_bib4","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/jxb\/erad456","article-title":"Aberrant accumulation of ceramides in mitochondria triggers cell death by inducing autophagy in Arabidopsis","volume":"75","author":"Bao","year":"2024","journal-title":"Journal of Experimental Botany"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-025-00843-y","article-title":"Apolipoprotein E in AD: Molecular insights and therapeutic opportunities","volume":"20","author":"Belaidi","year":"2025","journal-title":"Molecular Neurodegeneration"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s11658-025-00685-y","article-title":"Metabolic pathways of eicosanoids\u2014Derivatives of arachidonic acid and their significance in skin","volume":"30","author":"Biernacki","year":"2025","journal-title":"Cellular & Molecular Biology Letters"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/febs.16579","article-title":"Sphingosine 1-phosphate attenuates neuronal dysfunction induced by amyloid-\u03b2 oligomers through endocytic internalization of NMDA receptors","volume":"290","author":"Bigi","year":"2023","journal-title":"The FEBS Journal"},{"issue":"4","key":"10.1016\/bs.irn.2026.02.004_bib8","first-page":"1285","article-title":"Accelerated breakdown of phosphatidylcholine and phosphatidylethanolamine is a predominant brain metabolic defect in AD","volume":"93","author":"Blusztajn","year":"2023","journal-title":"Journal of AD"},{"key":"10.1016\/bs.irn.2026.02.004_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1123290","article-title":"Ketogenic interventions in mild cognitive impairment, AD, and Parkinson\u2019s disease: A systematic review and critical appraisal","volume":"14","author":"Bohnen","year":"2023","journal-title":"Frontiers in Neurology"},{"issue":"8","key":"10.1016\/bs.irn.2026.02.004_bib10","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.cmet.2021.07.006","article-title":"Astrocyte-neuron metabolic cooperation shapes brain activity","volume":"33","author":"Bonvento","year":"2021","journal-title":"Cell Metabolism"},{"key":"10.1016\/bs.irn.2026.02.004_bib11","article-title":"Cardiolipin deficiency disrupts electron transport chain to drive steatohepatitis","volume":"14","author":"Brothwell","year":"2025","journal-title":"eLife"},{"key":"10.1016\/bs.irn.2026.02.004_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2017.00060","article-title":"Lipid processing in the brain: A key regulator of systemic metabolism","volume":"8","author":"Bruce","year":"2017","journal-title":"Frontiers in Endocrinology"},{"issue":"3","key":"10.1016\/bs.irn.2026.02.004_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1039\/D0MO00186D","article-title":"Cerebrospinal fluid lipidomics for biomarkers of AD","volume":"17","author":"Byeon","year":"2021","journal-title":"Molecular Omics"},{"issue":"16","key":"10.1016\/bs.irn.2026.02.004_bib14","doi-asserted-by":"crossref","first-page":"8922","DOI":"10.3390\/ijms25168922","article-title":"Metabolic reprogramming of astrocytes in pathological conditions: Implications for neurodegenerative diseases","volume":"25","author":"Cal\u00ec","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.02.004_bib15","first-page":"29","article-title":"Chapter Two\u2014Phosphatidylethanolamine metabolism in health and disease","volume":"321","author":"Calzada","year":"2016"},{"issue":"9","key":"10.1016\/bs.irn.2026.02.004_bib16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3390\/metabo15090602","article-title":"Impact of dietary interventions on the human plasma and lipoprotein lipidome","volume":"15","author":"Casas","year":"2025","journal-title":"Metabolites"},{"issue":"6","key":"10.1016\/bs.irn.2026.02.004_bib17","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.bpj.2017.03.009","article-title":"Impact of GM1 on membrane-mediated aggregation\/oligomerization of \u03b2-amyloid: Unifying view","volume":"113","author":"Cebecauer","year":"2017","journal-title":"Biophysical Journal"},{"issue":"11","key":"10.1016\/bs.irn.2026.02.004_bib18","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3390\/biom14111362","article-title":"Exploring the dynamic changes of brain lipids, lipid rafts, and lipid droplets in aging and AD","volume":"14","author":"Cerasuolo","year":"2024","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/bs.irn.2026.02.004_bib19","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1074\/jbc.M111.274142","article-title":"Comparative lipidomic analysis of mouse and human brain with Alzheimer disease","volume":"287","author":"Chan","year":"2012","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.irn.2026.02.004_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00038","article-title":"Bioactive lipids and chronic inflammation: Managing the fire within","volume":"9","author":"Chiurchi\u00f9","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"11","key":"10.1016\/bs.irn.2026.02.004_bib21","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.3390\/ijms23116235","article-title":"Lipidomics of bioactive lipids in Alzheimer\u2019s and Parkinson\u2019s diseases: Where are we?","volume":"23","author":"Chiurchi\u00f9","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10.1016\/bs.irn.2026.02.004_bib22","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.3390\/ijms25094645","article-title":"The role of phospholipid alterations in mitochondrial and brain dysfunction after cardiac arrest","volume":"25","author":"Choudhary","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13195-023-01359-7","article-title":"Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in AD and vascular dementia","volume":"15","author":"Chua","year":"2023","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"9","key":"10.1016\/bs.irn.2026.02.004_bib24","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.3390\/biomedicines11092488","article-title":"Mitochondria and brain disease: A comprehensive review of pathological mechanisms and therapeutic opportunities","volume":"11","author":"Clemente-Su\u00e1rez","year":"2023","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/bs.irn.2026.02.004_bib25","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/advances\/nmaa180","article-title":"The efficacy of ketogenic therapies in the clinical management of people with neurodegenerative disease: A systematic review","volume":"12","author":"Dewsbury","year":"2021","journal-title":"Advances in Nutrition"},{"issue":"5","key":"10.1016\/bs.irn.2026.02.004_bib26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrn3012","article-title":"Linking lipids to AD: Cholesterol and beyond","volume":"12","author":"Di Paolo","year":"2011","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/bs.irn.2026.02.004_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2015.00052","article-title":"Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA and DHA","volume":"7","author":"Dyall","year":"2015","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"36","key":"10.1016\/bs.irn.2026.02.004_bib28","doi-asserted-by":"crossref","first-page":"24748","DOI":"10.1074\/jbc.M800352200","article-title":"Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: ROLES FOR CD14, LPS-BINDING PROTEIN, AND MD2 as targets for specificity of inhibition*","volume":"283","author":"Erridge","year":"2008","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/bs.irn.2026.02.004_bib29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.tem.2021.01.006","article-title":"Cardiolipin, mitochondria, and neurological disease","volume":"32","author":"Falabella","year":"2021","journal-title":"Trends in Endocrinology & Metabolism"},{"issue":"19","key":"10.1016\/bs.irn.2026.02.004_bib30","doi-asserted-by":"crossref","first-page":"10672","DOI":"10.3390\/ijms251910672","article-title":"Metabolic reprogramming of astrocytes in pathological conditions: Implications for neurodegenerative diseases","volume":"25","author":"Farooqui","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"10.1016\/bs.irn.2026.02.004_bib31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/cells13070609","article-title":"The role of cardiolipin in mitochondrial function and neurodegenerative diseases","volume":"13","author":"Fuentes","year":"2024","journal-title":"Cells"},{"issue":"7","key":"10.1016\/bs.irn.2026.02.004_bib32","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.3390\/cells10071721","article-title":"Cardiolipin, non-bilayer structures and mitochondrial bioenergetics: Relevance to cardiovascular disease","volume":"10","author":"Gasanoff","year":"2021","journal-title":"Cells"},{"key":"10.1016\/bs.irn.2026.02.004_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102643","article-title":"Mitochondrial cholesterol: Metabolism and impact on redox biology and disease","volume":"61","author":"Goicoechea","year":"2023","journal-title":"Redox Biology"},{"issue":"S2","key":"10.1016\/bs.irn.2026.02.004_bib34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/jnc.13583","article-title":"Overcoming translational barriers impeding development of AD modifying therapies","volume":"139","author":"Golde","year":"2016","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cmet.2013.11.020","article-title":"Aerobic glycolysis in the human brain is associated with development and neotenous gene expression","volume":"19","author":"Goyal","year":"2014","journal-title":"Cell Metabolism"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib36","article-title":"The impact of cholesterol, DHA, and sphingolipids on AD","volume":"2013","author":"Grimm","year":"2013","journal-title":"BioMed Research International"},{"issue":"4","key":"10.1016\/bs.irn.2026.02.004_bib37","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1021\/acschemneuro.3c00741","article-title":"Omega-3 and -6 fatty acids alter the membrane lipid composition and vesicle size to regulate exocytosis and storage of catecholamines","volume":"15","author":"Gu","year":"2024","journal-title":"ACS Chemical Neuroscience"},{"issue":"11","key":"10.1016\/bs.irn.2026.02.004_bib38","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.3390\/ijms24119558","article-title":"Ganglioside GM1 and the central nervous system","volume":"24","author":"Guo","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/bs.irn.2026.02.004_bib39","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1007\/s12035-023-03793-y","article-title":"Phospholipidomics in clinical trials for brain disorders: Advancing our understanding and therapeutic potentials","volume":"61","author":"Hachem","year":"2024","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.plipres.2010.09.001","article-title":"Apolipoprotein E: From lipid transport to neurobiology","volume":"50","author":"Hauser","year":"2011","journal-title":"Progress in Lipid Research"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13195-025-01830-7","article-title":"Integrated plasma and red blood cell membrane lipidomics analysis unveils novel biomarker panel for AD","volume":"17","author":"He","year":"2025","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-025-00803-6","article-title":"Lipidome disruption in AD brain: Detection, pathological mechanisms, and therapeutic implications","volume":"20","author":"He","year":"2025","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/bs.irn.2026.02.004_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103578","article-title":"Choline alleviates cognitive impairment in sleep-deprived young mice via reducing neuroinflammation and altering phospholipidomic profile","volume":"81","author":"Huang","year":"2025","journal-title":"Redox Biology"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12944-019-0965-z","article-title":"Role of cholesterol and sphingolipids in brain development and neurological diseases","volume":"18","author":"Hussain","year":"2019","journal-title":"Lipids in Health and Disease"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib45","article-title":"Ceramides in AD: Key mediators of neuronal apoptosis induced by oxidative stress and A\u03b2 accumulation","volume":"2015","author":"Jazvin\u0161\u0107ak Jembrek","year":"2015","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"11","key":"10.1016\/bs.irn.2026.02.004_bib46","doi-asserted-by":"crossref","first-page":"14424","DOI":"10.1007\/s12035-025-04989-0","article-title":"Ceramides may play a central role in the pathogenesis of AD: A review of evidence and horizons for discovery","volume":"62","author":"Kalkman","year":"2025","journal-title":"Molecular Neurobiology"},{"issue":"4","key":"10.1016\/bs.irn.2026.02.004_bib47","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3390\/ijms21041505","article-title":"Lipids and AD","volume":"21","author":"Kao","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.02.004_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2014.06.002","article-title":"Phosphatidylserine in the brain: Metabolism and function","volume":"56","author":"Kim","year":"2014","journal-title":"Progress in Lipid Research"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/metabo2010019","article-title":"Mass spectrometry based lipidomics: An overview of technological platforms","volume":"2","author":"K\u00f6feler","year":"2012","journal-title":"Metabolites"},{"issue":"11","key":"10.1016\/bs.irn.2026.02.004_bib50","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1176\/appi.ajp.2021.19080873","article-title":"Amyloid and Tau in AD: Biomarkers or molecular targets for therapy? Are we shooting the messenger?","volume":"178","author":"Kumar","year":"2021","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1016\/bs.irn.2026.02.004_bib51","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.3390\/ijms25052483","article-title":"Plasma lipidomic profiling using mass spectrometry for multiple sclerosis diagnosis and disease activity stratification (LipidMS)","volume":"25","author":"Lattau","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/bs.irn.2026.02.004_bib52","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1471-4159.2004.02183.x","article-title":"A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes","volume":"88","author":"Liang","year":"2004","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2026.02.004_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.747284","article-title":"The ketogenic effect of medium-chain triacylglycerides","volume":"8","author":"Lin","year":"2021","journal-title":"Frontiers in Nutrition"},{"issue":"2","key":"10.1016\/bs.irn.2026.02.004_bib54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nature Reviews Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40035-024-00432-x","article-title":"Updates in AD: From basic research to diagnosis and therapies","volume":"13","author":"Liu","year":"2024","journal-title":"Translational Neurodegeneration"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib56","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41398-021-01362-2","article-title":"Plasma lipidome is dysregulated in AD and is associated with disease risk genes","volume":"11","author":"Liu","year":"2021","journal-title":"Translational Psychiatry"},{"issue":"23","key":"10.1016\/bs.irn.2026.02.004_bib57","doi-asserted-by":"crossref","first-page":"13207","DOI":"10.3390\/ijms252313207","article-title":"Diacylglycerol kinases and its role in lipid metabolism and related diseases","volume":"25","author":"Liu","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10.1016\/bs.irn.2026.02.004_bib58","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/biomedicines8090295","article-title":"The biomedical uses of inositols: A nutraceutical approach to metabolic dysfunction in aging and neurodegenerative diseases","volume":"8","author":"L\u00f3pez-Gambero","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/bs.irn.2026.02.004_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2025.102734","article-title":"Current amyloid inhibitors: Therapeutic applications and nanomaterial-based innovations","volume":"247","author":"L\u00f3pez-Garc\u00eda","year":"2025","journal-title":"Progress in Neurobiology"},{"issue":"8","key":"10.1016\/bs.irn.2026.02.004_bib60","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.261281","article-title":"A\u03b2 peptide enhances GluA1 internalization via lipid rafts in Alzheimer\u2019s-related hippocampal LTP dysfunction","volume":"137","author":"Midorikawa","year":"2024","journal-title":"Journal of Cell Science"},{"issue":"7","key":"10.1016\/bs.irn.2026.02.004_bib61","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1212\/WNL.0b013e318264e380","article-title":"Serum ceramides increase the risk of Alzheimer disease","volume":"79","author":"Mielke","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2026.02.004_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.617588","article-title":"Mitochondrial dysfunction and oxidative stress in AD","volume":"13","author":"Misrani","year":"2021","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"4","key":"10.1016\/bs.irn.2026.02.004_bib63","first-page":"1375","article-title":"Cardiolipin profile changes are associated to the early synaptic mitochondrial dysfunction in AD","volume":"43","author":"Monteiro-Cardoso","year":"2014","journal-title":"Journal of AD"},{"issue":"6","key":"10.1016\/bs.irn.2026.02.004_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112557","article-title":"PUFAs in lipid membranes regulate human neuronal function and amyloid-\u03b2 production","volume":"28","author":"Morita","year":"2025","journal-title":"iScience"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib65","first-page":"43","article-title":"AD puzzle: Delving into pathogenesis hypotheses","volume":"15","author":"Nasb","year":"2024","journal-title":"Aging and Disease"},{"issue":"11","key":"10.1016\/bs.irn.2026.02.004_bib66","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/carcin\/bgi163","article-title":"The role of DHAin mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes","volume":"26","author":"Ng","year":"2005","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/bs.irn.2026.02.004_bib67","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the global burden of disease study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"The Lancet Public Health"},{"issue":"6","key":"10.1016\/bs.irn.2026.02.004_bib68","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.bbamem.2013.11.010","article-title":"Lipid replacement therapy: A natural medicine approach to replacing damaged lipids in cellular membranes and organelles and restoring function","volume":"1838","author":"Nicolson","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA)\u00a0- Biomembranes"},{"issue":"36","key":"10.1016\/bs.irn.2026.02.004_bib69","doi-asserted-by":"crossref","first-page":"24707","DOI":"10.1074\/jbc.M801810200","article-title":"Long-chain ceramide is a potent inhibitor of the mitochondrial permeability transition pore","volume":"283","author":"Novgorodov","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/bs.irn.2026.02.004_bib70","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170069","article-title":"Sphingolipids: Membrane microdomains in brain development, function and neurological diseases","volume":"7","author":"Olsen","year":"2017","journal-title":"Open Biology"},{"issue":"9","key":"10.1016\/bs.irn.2026.02.004_bib71","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/biomedicines8090306","article-title":"The anti-inflammatory and antioxidant properties of n-3 PUFAs: Their role in cardiovascular protection","volume":"8","author":"Oppedisano","year":"2020","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib72","article-title":"Cholesterol: Its regulation and role in central nervous system disorders","volume":"2012","author":"Orth","year":"2012","journal-title":"Cholesterol"},{"issue":"11","key":"10.1016\/bs.irn.2026.02.004_bib73","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.3390\/molecules28114316","article-title":"Membrane lipid derivatives: Roles of arachidonic acid and its metabolites in pancreatic physiology and pathophysiology","volume":"28","author":"Ortiz-Plac\u00edn","year":"2023","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/bs.irn.2026.02.004_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1348410","article-title":"A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, AD, and their co-morbidities","volume":"15","author":"Pan","year":"2024","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2026.02.004_bib75","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbabio.2013.10.006","article-title":"Functional role of cardiolipin in mitochondrial bioenergetics","volume":"1837","author":"Paradies","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA)\u00a0- Bioenergetics"},{"issue":"7","key":"10.1016\/bs.irn.2026.02.004_bib76","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/cells8070728","article-title":"Role of cardiolipin in mitochondrial function and dynamics in health and disease: Molecular and pharmacological aspects","volume":"8","author":"Paradies","year":"2019","journal-title":"Cells"},{"key":"10.1016\/bs.irn.2026.02.004_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101723","article-title":"Influence of genetic and cardiometabolic risk factors in AD","volume":"81","author":"Pasqualetti","year":"2022","journal-title":"Ageing Research Reviews"},{"issue":"11","key":"10.1016\/bs.irn.2026.02.004_bib78","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3390\/antiox9111128","article-title":"Lipid peroxidation and antioxidant supplementation in neurodegenerative diseases: A review of human studies","volume":"9","author":"Petrovic","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/bs.irn.2026.02.004_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.807639","article-title":"Molecular pharmacology and novel potential therapeutic applications of fingolimod","volume":"13","author":"Pournajaf","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"17","key":"10.1016\/bs.irn.2026.02.004_bib80","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"DHAsupplementation and cognitive decline in Alzheimer disease: A randomized trial","volume":"304","author":"Quinn","year":"2010","journal-title":"JAMA: the Journal of the American Medical Association"},{"issue":"9","key":"10.1016\/bs.irn.2026.02.004_bib81","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.bbamem.2018.03.004","article-title":"Cause and consequence of A\u03b2 \u2013 Lipid interactions in Alzheimer disease pathogenesis","volume":"1860","author":"Rangachari","year":"2018","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib82","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in AD: Pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Molecular Neurodegeneration"},{"issue":"16","key":"10.1016\/bs.irn.2026.02.004_bib83","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3390\/cells12162019","article-title":"Hypometabolism, AD, and possible therapeutic targets: An overview","volume":"12","author":"Raut","year":"2023","journal-title":"Cells"},{"key":"10.1016\/bs.irn.2026.02.004_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2025.07.030","article-title":"Artificial intelligence-driven multi-omics approaches in AD: Progress, challenges, and future directions","author":"Ren","year":"2025","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/bs.irn.2026.02.004_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.937056","article-title":"Cholesterol as a key player in amyloid \u03b2-mediated toxicity in AD","volume":"15","author":"Rudajev","year":"2022","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib86","first-page":"524","article-title":"Plasmalogen deficiency and neuropathology in AD: Causation or coincidence?","volume":"5","author":"Senanayake","year":"2019","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions"},{"issue":"8","key":"10.1016\/bs.irn.2026.02.004_bib87","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/s12276-024-01273-4","article-title":"Cholesterol imbalance and neurotransmission defects in neurodegeneration","volume":"56","author":"Shin","year":"2024","journal-title":"Experimental & Molecular Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2026.02.004_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.1545","article-title":"Complement and microglia dependent synapse elimination in brain development","volume":"14","author":"Soteros","year":"2022","journal-title":"WIREs Mechanisms of Disease"},{"key":"10.1016\/bs.irn.2026.02.004_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.592607","article-title":"Synaptic loss in AD: Mechanistic insights provided by two-photon in vivo imaging of transgenic mouse models","volume":"14","author":"Subramanian","year":"2020","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2026.02.004_bib90","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4062\/biomolther.2012.20.2.152","article-title":"Effects of DHAon neurotransmission","volume":"20","author":"Tanaka","year":"2012","journal-title":"Biomolecules & Therapeutics"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib91","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/71366","article-title":"Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles","volume":"2","author":"Thiele","year":"2000","journal-title":"Nature Cell Biology"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib92","article-title":"Omega-3 fatty acids in early prevention of inflammatory neurodegenerative disease: A focus on AD","volume":"2015","author":"Thomas","year":"2015","journal-title":"BioMed Research International"},{"key":"10.1016\/bs.irn.2026.02.004_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114827","article-title":"Abnormalities of glucose and lipid metabolism in myocardial ischemia-reperfusion injury","volume":"163","author":"Tian","year":"2023","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib94","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10571-025-01543-3","article-title":"The effects and mechanisms of n-3 and n-6 PUFAs in the central nervous system","volume":"45","author":"Tian","year":"2025","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/bs.irn.2026.02.004_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00010","article-title":"Neuronal lipid metabolism: Multiple pathways driving functional outcomes in health and disease","volume":"11","author":"Tracey","year":"2018","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2026.02.004_bib96","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.apsb.2021.10.002","article-title":"Apolipoprotein E and AD","volume":"12","author":"Troutwine","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"11","key":"10.1016\/bs.irn.2026.02.004_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2022.184033","article-title":"The synaptic lipidome in health and disease","volume":"1864","author":"Vall\u00e9s","year":"2022","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"key":"10.1016\/bs.irn.2026.02.004_bib98","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.addr.2020.04.009","article-title":"Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods","volume":"159","author":"van Kruining","year":"2020","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib99","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/jnc.14886","article-title":"Phosphatidylserine is critical for vesicle fission during clathrin-mediated endocytosis","volume":"152","author":"Varga","year":"2020","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"10.1016\/bs.irn.2026.02.004_bib100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","article-title":"Amyloid \u03b2 oligomers in AD pathogenesis, treatment, and diagnosis","volume":"129","author":"Viola","year":"2015","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib101","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of AD: Recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Molecular Neurodegeneration"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib102","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12944-025-02563-0","article-title":"Lipid rafts: Novel therapeutic targets for metabolic, neurodegenerative, oncological, and cardiovascular diseases","volume":"24","author":"Warda","year":"2025","journal-title":"Lipids in Health and Disease"},{"key":"10.1016\/bs.irn.2026.02.004_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.719159","article-title":"Alterations in glycerolipid and fatty acid metabolic pathways in AD identified by urinary metabolic profiling: A pilot study","volume":"12","author":"Watanabe","year":"2021","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib104","article-title":"Statin use and dementia risk: A systematic review and updated meta-analysis","volume":"11","author":"Westphal Filho","year":"2025","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/bs.irn.2026.02.004_bib105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ibneur.2023.08.2194","article-title":"The effect of lipid metabolism on age-associated cognitive decline: Lessons learned from model organisms and human","volume":"15","author":"Wu","year":"2023","journal-title":"IBRO Neuroscience Reports"},{"issue":"8","key":"10.1016\/bs.irn.2026.02.004_bib106","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tem.2023.05.002","article-title":"Apolipoprotein E in lipid metabolism and neurodegenerative disease","volume":"34","author":"Yang","year":"2023","journal-title":"Trends in Endocrinology & Metabolism"},{"issue":"6","key":"10.1016\/bs.irn.2026.02.004_bib107","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid metabolism and AD: Clinical evidence, mechanistic link and therapeutic promise","volume":"290","author":"Yin","year":"2023","journal-title":"The FEBS Journal"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib108","article-title":"Sphingolipid and ceramide homeostasis: Potential therapeutic targets","volume":"2012","author":"Young","year":"2012","journal-title":"Biochemistry Research International"},{"issue":"1","key":"10.1016\/bs.irn.2026.02.004_bib109","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/CS20200844","article-title":"Mitochondria-associated membranes (MAMs): A potential therapeutic target for treating AD","volume":"135","author":"Yu","year":"2021","journal-title":"Clinical Science"},{"key":"10.1016\/bs.irn.2026.02.004_bib110","doi-asserted-by":"crossref","unstructured":"Yui, K., Imataka, G., Nakamura, H., Ohara, N., & Naito, Y. (n.d.). Eicosanoids derived from arachidonic acid and their family prostaglandins and cyclooxygenase in psychiatric disorders. Current Neuropharmacology, 13(6), 776\u2013785. https:\/\/doi.org\/10.2174\/1570159\u00d713666151102103305.","DOI":"10.2174\/1570159X13666151102103305"},{"issue":"11","key":"10.1016\/bs.irn.2026.02.004_bib111","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jnr.24064","article-title":"The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction","volume":"95","author":"Zilberter","year":"2017","journal-title":"Journal of Neuroscience Research"}],"container-title":["International Review of Neurobiology","Brain Energy Metabolism in Alzheimers Disease - Part C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:17:45Z","timestamp":1785874665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774226000243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443345258"],"references-count":111,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2026.02.004","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}